NanoString Technologies
OverviewSuggest Edit
NanoString Technologies is a provider of life science tools for translational research and molecular diagnostics. The company offers nCounter Analysis System, an automated, multi-application, digital detection, and counting system; nCounter MAX and FLEX systems that include Prep Station, an automated liquid handling component that processes and prepares samples for data collection; and nCounter Digital Analyzer, which collects data from samples by taking images of the immobilized fluorescent reporters in the sample cartridge and processing the data into output files. It also offers nCounter SPRINT Profiler, an instrument that provides liquid handling steps and the digital analysis through use of a microfluidic cartridge; and nSolver Analysis Software, a data analysis program that enables researchers to check, normalize, and analyze their data. In addition, it provides custom CodeSets; and pan cancer and 360 gene expression, CAR-T characterization, neuropathology and neuro-inflammation gene expression, autoimmune disease gene expression, miRNA expression, human organ transplant, human and mouse metabolic pathway, and human and mouse fibrosis panels.
| Type | Public | |
| Founded | 2003 | |
| HQ | Seattle, WA, US | Map |
| Website | nanostring.com | |
| Employee Ratings | More | |
| Overall Culture | D- | More |
Recent NewsAll News
- Worldwide Industry for Spatial Genomics and Transcriptomics to 2030 - Players Include NanoString Technologies, S2 Genomics & Flagship Biosciences Among Others
- NanoString Technologies Announces Pricing of Public Offering of 4,500,000 Shares of Common Stock
- NanoString Technologies Announces Commencement of Public Offering of Common Stock
- NanoString Technologies Provides Preliminary Operational and Financial Results for Fourth Quarter and Fiscal Year 2018
Key People/Management at NanoString Technologies
Brad Gray
President and Chief Executive Officer
J. Chad Brown
Senior Vice President, Sales and Marketing
Kathy Surace-Smith
Vice President, General Counsel and Corporate Secretary
Thomas Bailey
Chief Financial Officer
Joseph M. Beechem
Chief Scientific Officer & Senior Vice President, Research & Development
Janet George
Director
NanoString Technologies Office Locations
NanoString Technologies has an office in Seattle
Seattle, WA, US (HQ)
530 Fairview Ave N #2000
NanoString Technologies Financials and Metrics
NanoString Technologies Revenue
NanoString Technologies's revenue was reported to be $117.32 m in FY, 2020
| USD | |
|---|---|
Revenue (Q1, 2021) | 31.6m |
Gross profit (Q1, 2021) | 16.0m |
Gross profit margin (Q1, 2021), % | 50.6% |
Net income (Q1, 2021) | (27.7m) |
EBIT (Q1, 2021) | (25.9m) |
Market capitalization (14-Sept-2021) | 2.5b |
Closing stock price (14-Sept-2021) | 56.0 |
Cash (31-Mar-2021) | 396.5m |
EV | 2.4b |
NanoString Technologies's current market capitalization is $2.5 b.
Annual
Quarterly
| USD | Q1, 2017 | Q2, 2017 | Q3, 2017 | Q1, 2018 | Q2, 2018 | Q3, 2018 | Q1, 2019 | Q2, 2019 | Q3, 2019 | Q1, 2020 | Q2, 2020 | Q1, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 18.1m | 34.6m | 27.0m | 23.1m | 25.0m | 28.6m | 27.7m | 30.3m | 30.6m | 26.6m | 21.1m | 31.6m |
Cost of goods sold | 7.2m | 8.2m | 7.3m | 7.7m | 8.6m | 9.3m | 8.7m | 9.6m | 10.9m | 11.0m | 15.6m | |
Gross profit | 10.9m | 26.4m | 19.7m | 15.4m | 16.4m | 19.3m | 19.0m | 20.7m | 19.7m | 15.6m | 16.0m | |
Gross profit Margin, % | 60% | 76% | 73% | 67% | 66% | 68% | 69% | 68% | 64% | 59% | 51% |
Annual
Quarterly
| USD | Q1, 2017 | Q2, 2017 | Q3, 2017 | Q1, 2018 | Q2, 2018 | Q3, 2018 | Q1, 2019 | Q2, 2019 | Q3, 2019 | Q1, 2020 | Q2, 2020 | Q1, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cash | 5.4m | 40.6m | 28.8m | 15.6m | 24.3m | 21.2m | 84.1m | 33.4m | 23.4m | 155.6m | 168.4m | 396.5m |
Accounts Receivable | 16.7m | 18.5m | 18.3m | 16.3m | 17.4m | 18.5m | 18.1m | 19.0m | 19.5m | 21.2m | 22.0m | 33.2m |
Prepaid Expenses | 4.0m | 5.3m | 6.1m | 5.8m | 5.9m | 7.1m | 8.6m | 9.2m | 10.9m | 5.4m | 3.2m | 6.9m |
Inventories | 14.5m | 15.8m | 18.5m | 19.1m | 17.6m | 15.0m | 13.0m | 16.5m | 19.0m | 22.2m | 26.0m | 24.4m |
Annual
Quarterly
| USD | Q1, 2017 | Q2, 2017 | Q3, 2017 | Q1, 2018 | Q2, 2018 | Q3, 2018 | Q1, 2019 | Q2, 2019 | Q3, 2019 | Q1, 2020 | Q2, 2020 | Q1, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | (18.9m) | (23.4m) | (34.8m) | (19.2m) | (39.8m) | (56.3m) | (21.9m) | (41.9m) | (64.7m) | (38.6m) | (65.8m) | (27.7m) |
Depreciation and Amortization | 814.0k | 1.7m | 2.5m | 928.0k | 2.0m | 3.0m | 1.2m | 2.4m | 3.6m | 1.2m | 2.8m | 1.4m |
Inventories | (837.0k) | (2.5m) | (5.9m) | 817.0k | 1.6m | 3.5m | (465.0k) | (4.4m) | (7.2m) | (2.7m) | (6.6m) | (2.2m) |
Accounts Payable | (2.1m) | (392.0k) | (1.7m) | 716.0k | 1.1m | 1.3m | (1.9m) | (2.6m) | (2.0m) | (260.0k) | (2.8m) | 943.0k |
| USD | Q1, 2017 |
|---|---|
Debt/Equity | -15.6 x |
Debt/Assets | 0.4 x |
Financial Leverage | -34.8 x |
NanoString Technologies Acquisitions / Subsidiaries
| Company Name | Date | Deal Size |
|---|---|---|
| NanoString Technologies Asia Pacific Limited | ||
| NanoString Technologies (Bejing) Co. Ltd. | ||
| NanoString Technologies Europe Limited | ||
| NanoString Technologies Germany GmbH | ||
| NanoString Technologies International | ||
| NanoString Technologies SAS | ||
| NanoString Technologies Singapore Pte Limited | ||
| NanoString Technologies Spain, S.L. |
NanoString Technologies Revenue Breakdown
NanoString Technologies revenue breakdown by business segment: 24.7% from Instruments, 41.1% from Consumables, 7.5% from In Vitro Diagnostic Kits, 9.3% from Service and 17.4% from Collaboration
NanoString Technologies revenue breakdown by geographic segment: 68.6% from Americas, 24.1% from Europe & Middle East and 7.3% from Asia Pacific
NanoString Technologies Cybersecurity Score
NanoString Technologies Online and Social Media Presence
6.04k Twitter followers
NanoString Technologies has 6.04k Twitter Followers. The number of followers has increased 1.1% month over month and increased 3% quarter over quarter
NanoString Technologies's Trends
Twitter Engagement Stats for @nanostringtech
2.5k
Tweets
1.6k
Following
6k
Followers
93
Tweets last 30 days
1.9
Avg. likes per Tweet
80.6%
Tweets with engagement
NanoString Technologies Company Culture
Overall Culture
D-
56/100
CEO Rating
C+
68/100
Compensation
C+
68/100
NanoString Technologies News and Updates
December 08, 2020
Worldwide Industry for Spatial Genomics and Transcriptomics to 2030 - Players Include NanoString Technologies, S2 Genomics & Flagship Biosciences Among Others
Dublin, Dec. 08, 2020 (GLOBE NEWSWIRE) -- The "Global Spatial Genomics and Transcriptomics Market: Focus on Product Type, Sample Type, Workflow, Application, End User, Region and Competitive Landscape - Analysis and Forecast, 2020-2030" report has been added to ResearchAndMarkets.com's offering.
March 19, 2019
NanoString Technologies Announces Pricing of Public Offering of 4,500,000 Shares of Common Stock
SEATTLE, March 19, 2019 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced the pricing of an underwritten public offering of 4,500,000 shares of its common stock at a price …
March 18, 2019
NanoString Technologies Announces Commencement of Public Offering of Common Stock
SEATTLE, March 18, 2019 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced an underwritten public offering of 4,500,000 shares of its common stock pursuant to its shelf regi…
January 07, 2019
NanoString Technologies Provides Preliminary Operational and Financial Results for Fourth Quarter and Fiscal Year 2018
— FY18 Product and Service Revenue of $83.5 million, Exceeding High-End of Guidance —— Generated Pre-Orders for More Than 30 GeoMx™ Digital Spatial Profilers —
NanoString Technologies Blogs
September 09, 2021
A Lab of Young Brainiacs Widens the Horizons in the Fight Against Neurological Diseases. Q&A with the Liddelow Lab.
The Liddelow Lab is part of the Neuroscience Institute at NYU Langone. The lab’s research focus is astrocytes and their...
The post A Lab of Young Brainiacs Widens the Horizons in the Fight Against Neurological Diseases. Q&A with the Liddelow Lab. appeared first on NanoString.
August 31, 2021
Congratulations! Sarah Warren, PSBJ 40 Under 40 Honoree. Read Her Story.
The 40 Under 40 program, now in its 23rd year, includes professionals from life sciences, health care, aerospace, tech, food...
The post Congratulations! Sarah Warren, PSBJ 40 Under 40 Honoree. Read Her Story. appeared first on NanoString.
August 16, 2021
The Partnership between NanoString and ROSALIND. The Experience of a Stem Cell Genomics and Microscopy Core in Sunny California.
In October 2020, NanoString® Technologies and ROSALIND announced a partnership to grant global access to the ROSALIND® Bioinformatics Platform for...
The post The Partnership between NanoString and ROSALIND. The Experience of a Stem Cell Genomics and Microscopy Core in Sunny California. appeared fir…
July 26, 2021
Next Frontier in Cellular Therapy: A Q&A on Characterizing CAR-T Cells on a Grand Scale
In early June 2021, NanoString and the Parker Institute for Cancer Immunotherapy (PICI) announced a multi-center collaboration to characterize 800...
The post Next Frontier in Cellular Therapy: A Q&A on Characterizing CAR-T Cells on a Grand Scale appeared first on NanoString.
July 05, 2021
What is Regenerative Medicine?
Regeneration or tissue renewal is an inherent characteristic of several mammalian tissues, such as epithelia and blood cells. In these...
The post What is Regenerative Medicine? appeared first on NanoString.
June 14, 2021
CRO Spotlight: Invest in Today for a Better Tomorrow. A Chat with Oncocyte™ on Its Vision for a Disease-Free Future.
Oncocyte™ is a molecular diagnostic company located in Irvine, CA. It provides services aimed to accelerate and optimize the diagnosis...
The post CRO Spotlight: Invest in Today for a Better Tomorrow. A Chat with Oncocyte™ on Its Vision for a Disease-Free Future. appeared first on NanoString.
NanoString Technologies Frequently Asked Questions
When was NanoString Technologies founded?
NanoString Technologies was founded in 2003.
Who are NanoString Technologies key executives?
NanoString Technologies's key executives are Brad Gray, J. Chad Brown and Kathy Surace-Smith.
How many employees does NanoString Technologies have?
NanoString Technologies has 551 employees.
What is NanoString Technologies revenue?
Latest NanoString Technologies annual revenue is $117.3 m.
What is NanoString Technologies revenue per employee?
Latest NanoString Technologies revenue per employee is $212.9 k.
Who are NanoString Technologies competitors?
Competitors of NanoString Technologies include Personalis, EKF Diagnostics and Klox Technologies.
Where is NanoString Technologies headquarters?
NanoString Technologies headquarters is located at 530 Fairview Ave N #2000, Seattle.
Where are NanoString Technologies offices?
NanoString Technologies has an office in Seattle.
How many offices does NanoString Technologies have?
NanoString Technologies has 1 office.
Learn about Craft real-time company insights
Receive alerts for 300+ data fields across thousands of companies